Rath BA - Search Results

1

Incidence, Disease Severity, and Follow-Up of Influenza A/A, A/B, and B/B Virus Dual Infections in Children: A Hospital-Based Digital Surveillance Program.

Obermeier PE, Seeber LD, Alchikh M, Schweiger B, Rath BA. Obermeier PE, et al. Among authors: rath ba. Viruses. 2022 Mar 14;14(3):603. doi: 10.3390/v14030603. Viruses. 2022. PMID: 35337010 Free PMC article.

2

Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.

Rath B, von Kleist M, Tief F, Karsch K, Tuerk E, Muehlhans S, Louis F, Skopnik H, Schweiger B, Duwe S. Rath B, et al. Pediatr Infect Dis J. 2012 Sep;31(9):899-905. doi: 10.1097/INF.0b013e31825c7304. Pediatr Infect Dis J. 2012. PMID: 22581220

3

Early detection of influenza A and B infection in infants and children using conventional and fluorescence-based rapid testing.

Rath B, Tief F, Obermeier P, Tuerk E, Karsch K, Muehlhans S, Adamou E, Duwe S, Schweiger B. Rath B, et al. J Clin Virol. 2012 Dec;55(4):329-33. doi: 10.1016/j.jcv.2012.08.002. Epub 2012 Aug 24. J Clin Virol. 2012. PMID: 22921515

4

Towards a personalised approach to managing influenza infections in infants and children - food for thought and a note on oseltamivir.

Rath B, Tief F, Karsch K, Muehlhans S, Obermeier P, Adamou E, Chen X, Seeber L, Peiser C, Hoppe C, von Kleist M, Conrad T, Schweiger B. Rath B, et al. Infect Disord Drug Targets. 2013 Feb;13(1):25-33. doi: 10.2174/18715265112129990005. Infect Disord Drug Targets. 2013. PMID: 23675924

5

Introducing new vaccines in developing countries.

Kochhar S, Rath B, Seeber LD, Rundblad G, Khamesipour A, Ali M; Vienna Vaccine Safety Initiative. Kochhar S, et al. Expert Rev Vaccines. 2013 Dec;12(12):1465-78. doi: 10.1586/14760584.2013.855612. Expert Rev Vaccines. 2013. PMID: 24195483 Free article. Review.

6

Standardization and simplification of vaccination records.

Maurer W, Seeber L, Rundblad G, Kochhar S, Trusko B, Kisler B, Kush R, Rath B; Vienna Vaccine Safety Initiative. Maurer W, et al. Expert Rev Vaccines. 2014 Apr;13(4):545-59. doi: 10.1586/14760584.2014.892833. Epub 2014 Mar 6. Expert Rev Vaccines. 2014. PMID: 24597495 Free article. Review.

7

Quantitative influenza follow-up testing (QIFT)--a novel biomarker for the monitoring of disease activity at the point-of-care.

Chen X, Pouran Yousef K, Duwe S, Karsch K, Grover S, Wählisch S, Obermeier P, Tief F, Mühlhans S, Seeber L, von Kleist M, Schweiger B, Rath B. Chen X, et al. PLoS One. 2014 Mar 21;9(3):e92500. doi: 10.1371/journal.pone.0092500. eCollection 2014. PLoS One. 2014. PMID: 24658130 Free PMC article.

8

Evaluation of novel second-generation RSV and influenza rapid tests at the point of care.

Tuttle R, Weick A, Schwarz WS, Chen X, Obermeier P, Seeber L, Tief F, Muehlhans S, Karsch K, Peiser C, Duwe S, Schweiger B, Rath B. Tuttle R, et al. Diagn Microbiol Infect Dis. 2015 Mar;81(3):171-6. doi: 10.1016/j.diagmicrobio.2014.11.013. Epub 2014 Dec 3. Diagn Microbiol Infect Dis. 2015. PMID: 25583129

9

The impact of the parent-physician relationship on parental vaccine safety perceptions.

Kundi M, Obermeier P, Helfert S, Oubari H, Fitzinger S, Yun JA, Brix M, Rath B. Kundi M, et al. Curr Drug Saf. 2015;10(1):16-22. doi: 10.2174/157488631001150407104320. Curr Drug Saf. 2015. PMID: 25859670

10

A design thinking approach to effective vaccine safety communication.

Seeber L, Michl B, Rundblad G, Trusko B, Schnjakin M, Meinel C, Weinberg U, Gaedicke G, Rath B. Seeber L, et al. Curr Drug Saf. 2015;10(1):31-40. doi: 10.2174/157488631001150407105400. Curr Drug Saf. 2015. PMID: 25859673

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters